# TG Therapeutics, Inc.: Form 8-K, filed Mar 3, 2025

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: 8-K
- Filed: 2025-03-03
- Accepted by EDGAR: Mar 3, 2025, 07:19 ET
- Period: 2025-03-03
- Accession: 0001437749-25-005802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000143774925005802/tgtx20250225_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000143774925005802/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000143774925005802/tgtx20250225_8k.htm

Filed Mar 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-005802. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.